Company Overview
About Mantis Biotech
Mantis Biotech is a YC-backed AI company that builds digital twins of human physiology to synthesize diverse, realistic clinical trial populations. The company addresses one of drug development's most persistent problems: clinical trials consistently underrepresent women, elderly patients, and minorities, producing efficacy data that fails to predict real-world outcomes across populations. Mantis's AI platform generates synthetic patient data that fills these representation gaps.
Business Model & Competitive Advantage
The company emerged from stealth with a $48 million Series A in February 2026 co-led by Andreessen Horowitz's Bio fund and GV (Google Ventures), with a founding team led by CEO Georgia Witchel. The raise validates the thesis that AI-generated synthetic data can unlock clinical development stages that real-world data constraints currently block — including rare disease programs where patient populations are too small for statistically valid trials.
Competitive Landscape 2025–2026
Mantis targets the $2.6 billion average per-drug development cost, a figure dominated by late-stage trial failures that synthetic data simulation could predict earlier. As regulatory agencies warm to synthetic data for trial enrichment, Mantis is positioned at the intersection of AI, computational biology, and FDA regulatory strategy — a technically defensible and commercially timely position.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Mantis Biotech is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare Mantis Biotech with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Mantis Biotech? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Mantis Biotech Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Mantis Biotech vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →